Video Experimental Relacionado

Updated: May 28, 2026

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
10:27

Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria

Published on: November 10, 2015

La Fundación Lasker honra a un investigador del paludismo

Sharmila Devi

    Lancet (London, England)
    |October 5, 2011
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    A Multi-detection Assay for Malaria Transmitting Mosquitoes
    09:00

    A Multi-detection Assay for Malaria Transmitting Mosquitoes

    Published on: February 28, 2015

    An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
    08:14

    An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

    Published on: October 6, 2015

    Videos de Experimentos Relacionados

    Last Updated: May 28, 2026

    Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria
    10:27

    Methods to Increase the Sensitivity of High Resolution Melting Single Nucleotide Polymorphism Genotyping in Malaria

    Published on: November 10, 2015

    A Multi-detection Assay for Malaria Transmitting Mosquitoes
    09:00

    A Multi-detection Assay for Malaria Transmitting Mosquitoes

    Published on: February 28, 2015

    An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
    08:14

    An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

    Published on: October 6, 2015

    Videos de Conceptos Relacionados

    Malaria01:29

    Malaria

    Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
    Rous Sarcoma Virus (RSV) and Cancer01:03

    Rous Sarcoma Virus (RSV) and Cancer

    Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
    RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...

    Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

    Evaluation of the Endoscopic Third Ventriculostomy Success Score for Pediatric Hydrocephalus: Experience from a Singapore Children's Hospital.

    Pediatric neurosurgery·2025

    Multimodality Approach to a Pediatric Craniopharyngioma with Mixed Histological Features.

    Pediatric neurosurgery·2025

    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

    Lancet (London, England)·2026

    Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

    Lancet (London, England)·2026

    Advancing the relevance of clinical trials for older patients.

    Lancet (London, England)·2026

    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

    Lancet (London, England)·2026

    Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

    Lancet (London, England)·2026

    Insights into the Possible Composition of a Martian Biota.

    Astrobiology·2026

    The 2026 Richard Perham Prize winner: Angela M. Gronenborn.

    The FEBS journal·2026

    <b><i>Danolestes moelleri</i> gen. et sp. nov., the first lestoid (Zygoptera: Odonata) from the early Ypresian Fur Formation of Denmark shows faunistic affinity to South America</b>.

    Zootaxa·2026

    <b>The northernmost Eocene genus and species of praying mantises (Mantodea Burmeister, 1838) from Fur Formation, Denmark</b>.

    Zootaxa·2026

    Results and survival of Fassier-Duval rods in children with moderate Osteogenesis Imperfecta: a retrospective study in 36 cases

    Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina)·2026

    The 2026 Richard Perham Prize winner: Angela M. Gronenborn.

    The FEBS journal·2026
    Ver todos los artículos relacionados
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ACERCA DE JoVE
    Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
    AUTORES
    Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
    BIBLIOTECARIOS
    TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
    INVESTIGACIÓN
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
    EDUCACIÓN
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
    Términos y Condiciones de Uso
    Política de Privacidad
    Políticas
    Jove
    Visualize
    Contáctanos